查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1718073

牛膠原蛋白生物醫學應用市場（按產品類型、形式、來源、加工技術、應用和最終用戶分類）—2025 年至 2030 年全球預測

Bovine-Based Collagen for Biomedical Applications Market by Product Type, Type, Form, Source, Processing Technology, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計生物醫學應用的牛膠原蛋白市值在 2024 年將達到 12.4 億美元，在 2025 年將達到 13.3 億美元，預計複合年成長率為 7.71%，到 2030 年將達到 19.4 億美元。

主要市場統計數據
基準年2024年 12.4億美元
預計2025年 13.3億美元
預測年份 2030 19.4億美元
複合年成長率（%） 7.71%

牛膠原蛋白處於科學進步和臨床應用的交叉點，是現代生物醫學研究的重要組成部分。基於廣泛的研究和不斷發展的科學文獻，這種創新的生醫材料已成為從組織工程到傷口護理等廣泛應用的基石。最近的趨勢是臨床研究和產品開發激增，將牛膠原蛋白從傳統材料轉變為與再生醫學高度相關的材料。這種演變是由醫療保健專業人員的意識不斷增強以及對更多天然生醫材料的需求不斷增加所推動的。

在當前情況下，研究人員和臨床醫生不僅在創新提取技術，而且還在改進品質保證方法。這些進步提高了膠原蛋白蛋白製劑的生物相容性、降低了免疫抗原性反應、並提高了功能耐久性。隨著生物醫學界繼續追求永續性和自然資源的最佳化，牛膠原蛋白提供了符合這些當代優先事項的有希望的解決方案。對研發的大力投資也促進了學術界、生技公司和臨床專家之間的合作。跨學科專業知識的融合不斷揭示新的見解，為突破性的治療應用鋪平道路。

本介紹旨在為了解牛膠原蛋白如何重塑生物醫學應用提供一個全面的起點，同時為更深入分析定義當今動態格局的市場趨勢和技術轉變奠定基礎。

牛膠原蛋白格局的變革

近年來，創新轉變重新定義了牛膠原蛋白在生物醫學領域的角色。加工技術的進步顯著提高了膠原蛋白產品的產量、純度和生物利用度。調查方法利用酵素水解和高壓處理等尖端技術來微調分子結構並最佳化膠原蛋白產品的臨床功效。隨著法律規範不斷適應這些技術進步，市場上湧入越來越多的新進者，帶來了新的觀點和顛覆性的技術。

萃取技術的快速發展導致最終產品的高度客製化，從而能夠在再生醫學和組織工程等領域制定客製化的治療通訊協定。此外，採用新的分析方法可以更深入地了解膠原蛋白蛋白基質的組成和性能，為產品開發和臨床使用提供寶貴的數據。結果是提高了安全性，品質更加穩定，並為生物醫學材料樹立了新的標竿。

跨學科研究團隊和與商業組織的合作正在加速這一變化。這種充滿活力的環境不僅刺激了產品創新，也促進了人們更好地理解基於膠原蛋白的療法背後的基礎科學。新技術與傳統方法的融合不斷推動各方面的改進，促進下一代生物醫學解決方案所需的整體進步。

詳細研究膠原蛋白市場的關鍵細分見解

為了充分了解牛膠原蛋白市場的多面性，必須深入研究細分洞察，突顯該產業的複雜性和廣度。市場研究基於產品類型，其中區分明膠、水解膠原膠原蛋白和天然膠原膠原蛋白。在這方面，從水解和超濾明膠的角度對明膠本身進行了研究，突顯了分子尺寸和功能應用的差異。這種細分是理解市場動態的一個基本決定因素。

此外，基於類型的分割區分了 I膠原蛋白和 III 型膠原蛋白，每種膠原蛋白都與不同的生物結構和臨床功能相關。當考慮形式時，市場分析區分液體和粉末狀，從而認知到每種形式在臨床應用中的作用。基於來源的分割顯示，牛膠原蛋白來自骨骼、軟骨和皮膚。這種微妙的分類突出了每個特定來源的品質和性能的差異。

深入挖掘，基於加工技術的細分主要集中在酶水解和高壓處理等方法。具體來說，酵素水解可進一步分為酸性水解和鹼性水解，每種水解方式都會產生具有特定特性的膠原蛋白，以滿足特定的生物醫學需求。市場細分包括根據藥物傳輸系統、再生醫學、組織工程和傷口護理的應用對市場進行分析。再生醫學的主要領域進一步細分為軟骨修復和皮膚填充劑，展示了牛膠原蛋白的多功能性和廣泛的用途。

最後，根據最終用戶的細分區分學術和研究機構、生物技術公司以及醫院和診所。例如，在學術研究中，基礎生物醫學研究和臨床試驗之間存在明顯的差異。每個細分參數不僅提供了對市場動態的全面了解，而且還突出了生物醫藥行業有針對性的研究、產品創新和戰略投資的潛在途徑。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 人們對膠原蛋白治療益處的認知不斷提高，促進了膠原蛋白在各個醫療保健領域的應用。
      • 生醫藥Start-Ups創投資增加，服務範圍擴大
      • 全球人口老化導致骨骼相關疾病的盛行率上升
    • 限制因素
      • 複雜精密的生產流程帶來的高成本
    • 機會
      • 持續進行創傷治療和再生醫學的研究和開發
      • 牙科和整形外科手術需求增加
    • 任務
      • 確保牛膠原蛋白材料的安全性，最大程度降低疾病傳播的風險
  • 市場區隔分析
    • 產品類型：明膠用途廣泛且具有生物相容性，因此應用範圍十分廣泛。
    • 應用：牛膠原蛋白在再生醫學、藥物傳遞和組織工程的應用創新
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 生物醫學應用牛膠原蛋白市場（依產品類型）

  • 明膠
    • 水解明膠
    • 超濾明膠
  • 水解膠原膠原蛋白
  • 天然膠原膠原蛋白

7. 生物醫學應用牛膠原蛋白市場（按類型）

  • I型
  • III型

8. 生物醫學應用牛膠原蛋白市場（依形態）

  • 液體
  • 粉末

9. 生物醫學應用牛膠原蛋白市場（依來源）

  • 牛
  • 牛軟骨
  • 牛皮

10. 生物醫學應用牛膠原蛋白市場（依加工技術）

  • 酵素水解
    • 酸水解
    • 鹼性水解
  • 高壓處理

第 11 章。生物醫學應用牛膠原蛋白市場（依應用）

  • 藥物輸送系統
  • 再生醫學
    • 軟骨修復
    • 真皮填充劑
  • 組織工程
  • 創傷護理

第 12 章。生物醫學應用的牛膠原蛋白市場（按最終用戶）

  • 學術研究所
    • 基金會生物醫學研究
    • 臨床試驗
  • 生技公司
  • 醫院和診所

13. 美洲生物醫學應用牛膠原蛋白市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

14. 亞太地區牛膠原蛋白生物醫學應用市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

15. 歐洲、中東和非洲生物醫學應用牛膠原蛋白市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Advanced BioMatrix Inc. by BICP Group
  • Botiss biomaterials GmbH
  • Bovine Collagen Products LLC
  • Collagen Solutions PLC by Rosen's Diversified Inc.
  • Crescent Biotech
  • Darling Ingredients Inc.
  • Eucare Pharmaceuticals Private Limited
  • Getinge AB
  • Integra LifeSciences Holdings Corporation
  • Lapi Gelatine SpA
  • Medtronic PLC
  • Nippi Incorporated
  • Nitta Gelatin, Inc.
  • NuCollagen LLC
  • Regenity Biosciences
  • Symatese Group
  • Tessenderlo Group
  • Thermo Fisher Scientific Inc.
  • Titan Biotech Ltd.
  • Viscofan DE GmbH
Product Code: MRR-5C6F41F5B02B

The Bovine-Based Collagen for Biomedical Applications Market was valued at USD 1.24 billion in 2024 and is projected to grow to USD 1.33 billion in 2025, with a CAGR of 7.71%, reaching USD 1.94 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.24 billion
Estimated Year [2025] USD 1.33 billion
Forecast Year [2030] USD 1.94 billion
CAGR (%) 7.71%

Bovine-based collagen sits at the intersection of scientific advancement and clinical application, emerging as a pivotal element in modern biomedical research. Drawing on extensive research and an evolving body of scientific literature, this innovative biomaterial has been established as a cornerstone for applications ranging from tissue engineering to wound care. Over recent years, a surge in clinical studies and product development has transformed bovine collagen from a traditional material to one of high relevance for regenerative medicine. This evolution is attributed to enhanced awareness among healthcare professionals and an increasing demand for more natural biomaterials.

In the current scenario, researchers and clinicians are not only innovating in extraction techniques but are also refining quality assurance methods. These advances have led to improved biocompatibility, reduced immunogenic reactions, and increased functional durability of collagen-based formulations. As the biomedical community continues to embrace sustainability and natural resource optimization, bovine-based collagen offers a promising solution that aligns with these modern priorities. Deliberate investments in research and development have also spurred increased collaboration between academia, biotechnology firms, and clinical specialists. The convergence of cross-disciplinary expertise continues to reveal new insights that pave the way for groundbreaking therapeutic applications.

This introduction aims to provide a comprehensive starting point for understanding how bovine-based collagen is reshaping biomedical applications while simultaneously laying the foundation for deeper analysis of market trends and technological shifts that dictate today's dynamic landscape.

Transformative Shifts Reshaping the Bovine Collagen Landscape

In recent years, transformative shifts have redefined the role of bovine-based collagen in the biomedical field. Advancements in processing technology have significantly enhanced the yield, purity, and bioavailability of collagen products. Researchers are leveraging state-of-the-art methodologies such as enzymatic hydrolysis and high-pressure processing to fine-tune the molecular structure, thereby optimizing the clinical efficacy of these products. As regulatory frameworks continue to adapt to these innovations, the market experiences an increased influx of new entrants who bring fresh perspectives and disruptive technologies to the table.

Rapidly evolving extraction techniques have led to a higher degree of customization in the final products, allowing for tailored treatment protocols in areas like regenerative medicine and tissue engineering. The adoption of new analytical methods has also provided deep insights into the matrix composition and performance of collagen, generating valuable data that informs both product development and clinical practices. This has resulted in enhanced safety profiles and a more consistent quality, setting new benchmarks for biomedical materials.

Collaborative efforts between interdisciplinary research teams and commercial entities have accelerated these changes. This dynamic environment is not only stimulating product innovation but is also nurturing a better understanding of the fundamental science behind collagen-based therapies. The integration of novel technologies with traditional practices continues to drive improvements across the board, promoting a holistic advancement that is critical for the next generation of biomedical solutions.

Detailed Examination of Key Segmentation Insights in the Collagen Market

To thoroughly understand the multifaceted nature of the bovine collagen market, it is essential to delve into segmentation insights that underscore the complexity and breadth of this field. The market is studied based on product type, where distinctions are made between Gelatin, Hydrolyzed Collagen, and Native Collagen. In this regard, Gelatin itself is examined from the perspective of Hydrolyzed Gelatin and Ultra Filtered Gelatin, which highlights differences in molecular dimensions and functional applications. This segmentation serves as a fundamental determinant in understanding market dynamics.

Further segmentation based on type differentiates between Type I and Type III collagen, each associated with distinct biological structures and clinical functionalities. When considering the form, the market analysis differentiates between Liquid and Powder forms, thereby recognizing the role of each in varying clinical applications. Source-based segmentation reveals that bovine-derived collagen can originate from bone, cartilage, and skin. This nuanced classification underscores the varying quality and performance attributes derived from each specific source.

Delving deeper, the segmentation based on processing technology focuses on methodologies such as Enzymatic Hydrolysis and High-Pressure Processing. Notably, Enzymatic Hydrolysis is further dissected into Acidic Hydrolysis and Alkaline Hydrolysis, each producing collagen with particular characteristics tailored for specific biomedical needs. Looking at application segmentation, the market is analyzed by its use in Drug Delivery Systems, Regenerative Medicine, Tissue Engineering, and Wound Care. Regenerative Medicine, a leading sector, is further subdivided into Cartilage Repair and Dermal Fillers, which speaks to the versatility and broad usability of bovine collagen.

Finally, segmentation based on end-users distinguishes between Academic And Research Institutes, Biotechnology Companies, and Hospitals And Clinics. For instance, within academic research, there is a clear differentiation between basic biomedical research and clinical trials. Each segmentation parameter not only provides a comprehensive understanding of market dynamics but also highlights the potential avenues for targeted research, product innovation, and strategic investments in the biomedical industry.

Based on Product Type, market is studied across Gelatin, Hydrolyzed Collagen, and Native Collagen. The Gelatin is further studied across Hydrolyzed Gelatin and Ultra Filtered Gelatin.

Based on Type, market is studied across Type I and Type III.

Based on Form, market is studied across Liquid and Powder.

Based on Source, market is studied across Bovine Bone, Bovine Cartilage, and Bovine Skin.

Based on Processing Technology, market is studied across Enzymatic Hydrolysis and High-Pressure Processing. The Enzymatic Hydrolysis is further studied across Acidic Hydrolysis and Alkaline Hydrolysis.

Based on Application, market is studied across Drug Delivery Systems, Regenerative Medicine, Tissue Engineering, and Wound Care. The Regenerative Medicine is further studied across Cartilage Repair and Dermal Fillers.

Based on End User, market is studied across Academic And Research Institutes, Biotechnology Companies, and Hospitals And Clinics. The Academic And Research Institutes is further studied across Basic Biomedical Research and Clinical Trials.

Key Regional Insights Shaping the Global Collagen Market

Global demand for bovine-based collagen is influenced by a diverse range of regional markets that are integral to the overall growth of the biomedical industry. In the Americas, a robust healthcare infrastructure, combined with strong research networks and substantial investments in regenerative medicine, has created favorable conditions for advanced collagen applications. This region is marked by a rapid adoption of new technologies and a strong regulatory framework that encourages innovation.

In the Europe, Middle East & Africa region, traditional research centers and emerging biotech startups are paving new paths for utilizing collagen in clinical applications. The rich history of biomedical research in Europe, paired with cutting-edge developments in the Middle East and Africa, has further consolidated this region as a major player in the collagen landscape. Improvements in regulatory harmonization and cross-border collaborations have bolstered the market, creating a fertile ground for further technological advancements.

The Asia-Pacific region, with its dynamic economy and continuous investment in life sciences, is emerging as a powerhouse for both research and practical applications. High levels of academic output, combined with governmental efforts to foster innovative healthcare solutions, have positioned Asia-Pacific as a significant contributor to both the supply and application of bovine collagen. Together, these regions represent a globally interconnected market, each bringing unique strengths that collectively drive the upward trajectory of collagen-based biomedical applications.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation in Biomedical Collagen

A host of pioneering companies are leading the charge in the development and commercialization of bovine-based collagen products for biomedical applications. Among these leaders is Advanced BioMatrix Inc. by BICP Group, which has been at the forefront of biocompatible material innovations. Botiss biomaterials GmbH is another influential entity, renowned for incorporating rigorous quality standards into their product lines. Bovine Collagen Products LLC has also made significant contributions through strategic investments in research and development.

Collagen Solutions PLC by Rosen's Diversified Inc. has demonstrated a robust commitment to uncovering new application areas, while Crescent Biotech continues to blend technological innovation with practical clinical solutions. Darling Ingredients Inc. has effectively leveraged its extensive supply networks to provide high-quality resources, and Eucare Pharmaceuticals Private Limited has been instrumental in integrating collagen into advanced therapeutic modalities. Renowned global players such as Getinge AB and Integra LifeSciences Holdings Corporation have also laid out strong frameworks in product development.

Additional notable companies include Lapi Gelatine S.p.A., Medtronic PLC, and Nippi Incorporated, each bringing specialized expertise to the table. Nitta Gelatin, Inc. and NuCollagen LLC are recognized for their commitment to crafting high-purity products, while Regenity Biosciences elevates the application of collagen in regenerative medicine. Also influential are Symatese Group, Tessenderlo Group, Thermo Fisher Scientific Inc., Titan Biotech Ltd., and Viscofan DE GmbH. The collaboration and competition among these companies continue to drive innovation and set the stage for a transformative future in the biomedical application of collagen.

The report delves into recent significant developments in the Bovine-Based Collagen for Biomedical Applications Market, highlighting leading vendors and their innovative profiles. These include Advanced BioMatrix Inc. by BICP Group, Botiss biomaterials GmbH, Bovine Collagen Products LLC, Collagen Solutions PLC by Rosen's Diversified Inc., Crescent Biotech, Darling Ingredients Inc., Eucare Pharmaceuticals Private Limited, Getinge AB, Integra LifeSciences Holdings Corporation, Lapi Gelatine S.p.A., Medtronic PLC, Nippi Incorporated, Nitta Gelatin, Inc., NuCollagen LLC, Regenity Biosciences, Symatese Group, Tessenderlo Group, Thermo Fisher Scientific Inc., Titan Biotech Ltd., and Viscofan DE GmbH. Actionable Recommendations for Advancing Collagen Research and Applications

Industry leaders are encouraged to maintain a proactive stance by investing more in R&D and cultivating cross-functional collaborations that bridge clinical, academic, and technological perspectives. By emphasizing targeted research initiatives tailored to product type variations and advanced processing techniques, decision-makers can fine-tune the properties of bovine collagen to better suit the evolving needs of regenerative therapies. It is also recommended to harness data-driven strategies that capitalize on regional strengths and consumer trends to better anticipate market shifts. Furthermore, establishing strategic partnerships with academic and research institutions can ensure that the latest scientific breakthroughs are swiftly translated into practical, clinically beneficial applications.

Conclusion: Summarizing the Collagen Market Outlook

The bovine-based collagen market is characterized by a dynamic interplay of scientific innovation, technological refinement, and evolving clinical applications. The analysis underscores that progressive research, diversified segmentation, regional interdependence, and competitive corporate strategies are all pivotal to advancing biomedical collagen applications. As the collaborative efforts among key stakeholders continue to thrive, the market is poised for significant expansion and transformative growth, promising a brighter future for next-generation biomedical therapeutics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased awareness of collagen's therapeutic benefits fuels its use in diverse healthcare sectors
      • 5.1.1.2. Rising investments in biomedical startups to expand their offerings
      • 5.1.1.3. Growing aging of populations worldwide and increasing prevalence of bone-related diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with complex and intricate production processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D for the development of wound healing and regenerative medicines
      • 5.1.3.2. Growing demand for dental and orthopedic surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Ensuring safety and minimizing risk of disease transmission in bovine-derived collagen materials
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type : Wide applications of gelatin due to its versatility and biocompatibility
    • 5.2.2. Application : Innovation in bovine-based collagen applications in regenerative medicine, drug delivery, and tissue engineering
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bovine-Based Collagen for Biomedical Applications Market, by Product Type

  • 6.1. Introduction
  • 6.2. Gelatin
    • 6.2.1. Hydrolyzed Gelatin
    • 6.2.2. Ultra Filtered Gelatin
  • 6.3. Hydrolyzed Collagen
  • 6.4. Native Collagen

7. Bovine-Based Collagen for Biomedical Applications Market, by Type

  • 7.1. Introduction
  • 7.2. Type I
  • 7.3. Type III

8. Bovine-Based Collagen for Biomedical Applications Market, by Form

  • 8.1. Introduction
  • 8.2. Liquid
  • 8.3. Powder

9. Bovine-Based Collagen for Biomedical Applications Market, by Source

  • 9.1. Introduction
  • 9.2. Bovine Bone
  • 9.3. Bovine Cartilage
  • 9.4. Bovine Skin

10. Bovine-Based Collagen for Biomedical Applications Market, by Processing Technology

  • 10.1. Introduction
  • 10.2. Enzymatic Hydrolysis
    • 10.2.1. Acidic Hydrolysis
    • 10.2.2. Alkaline Hydrolysis
  • 10.3. High-Pressure Processing

11. Bovine-Based Collagen for Biomedical Applications Market, by Application

  • 11.1. Introduction
  • 11.2. Drug Delivery Systems
  • 11.3. Regenerative Medicine
    • 11.3.1. Cartilage Repair
    • 11.3.2. Dermal Fillers
  • 11.4. Tissue Engineering
  • 11.5. Wound Care

12. Bovine-Based Collagen for Biomedical Applications Market, by End User

  • 12.1. Introduction
  • 12.2. Academic And Research Institutes
    • 12.2.1. Basic Biomedical Research
    • 12.2.2. Clinical Trials
  • 12.3. Biotechnology Companies
  • 12.4. Hospitals And Clinics

13. Americas Bovine-Based Collagen for Biomedical Applications Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Bovine-Based Collagen for Biomedical Applications Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Bovine-Based Collagen for Biomedical Applications Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. RTI Surgical acquires Collagen Solutions to advance innovative biomedical applications
    • 16.3.2. Royal Wound-X launches the Peak Powder Collagen Matrix and ElectroFiber 3D to enhance wound healing
    • 16.3.3. MiMedx Group, Inc. entered an agreement with TELA Bio, Inc. to expand wound care portfolio with bovine collagen matrix innovation
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced BioMatrix Inc. by BICP Group
  • 2. Botiss biomaterials GmbH
  • 3. Bovine Collagen Products LLC
  • 4. Collagen Solutions PLC by Rosen's Diversified Inc.
  • 5. Crescent Biotech
  • 6. Darling Ingredients Inc.
  • 7. Eucare Pharmaceuticals Private Limited
  • 8. Getinge AB
  • 9. Integra LifeSciences Holdings Corporation
  • 10. Lapi Gelatine S.p.A.
  • 11. Medtronic PLC
  • 12. Nippi Incorporated
  • 13. Nitta Gelatin, Inc.
  • 14. NuCollagen LLC
  • 15. Regenity Biosciences
  • 16. Symatese Group
  • 17. Tessenderlo Group
  • 18. Thermo Fisher Scientific Inc.
  • 19. Titan Biotech Ltd.
  • 20. Viscofan DE GmbH

LIST OF FIGURES

  • FIGURE 1. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET MULTI-CURRENCY
  • FIGURE 2. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET MULTI-LANGUAGE
  • FIGURE 3. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET RESEARCH PROCESS
  • FIGURE 4. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 21. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 25. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 30. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 31. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY HYDROLYZED GELATIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ULTRA FILTERED GELATIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY HYDROLYZED COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY NATIVE COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BOVINE BONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BOVINE CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BOVINE SKIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACIDIC HYDROLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ALKALINE HYDROLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY HIGH-PRESSURE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BASIC BIOMEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 158. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 169. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 171. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 180. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 182. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 202. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 204. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 224. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 226. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 235. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 237. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 246. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 248. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 250. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 251. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PROCESSING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ENZYMATIC HYDROLYSIS, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY GELATIN, 2018-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILL